Location: Fort Worth, TX
CIK: 0001813845 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 13, 2026
Total Value: $52.87M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RNTX | REIN THERAPEUTICS INC | 1,982,375 (+17.2%) | $2.577M (+31.4%) | 4.9% | $2.76 | -55.3% | COM NEW | 00887A204 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LTRN | LANTERN PHARMA INC | 864,435 (-14.4%) | $1.184M (-61.3%) | 2.2% | $3.42 | -9.9% | COM | 51654W101 |
| INAB | IN8BIO INC | 167,805 (-33.8%) | $248K (-58.1%) | 0.5% | $1.90 | +8.2% | COM NEW | 45674E208 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACTU | ACTUATE THERAPEUTICS INC | 10,049,996 | $27.54M | 52.1% | $8.16 | -38.2% | COM | 005083100 |
| IRD | OPUS GENETICS INC | 3,683,429 | $16.76M | 31.7% | $0.99 | +178.1% | COM | 67577R102 |
| CGTX | COGNITION THERAPEUTICS INC | 6,000,000 | $4.56M | 8.6% | $0.49 | +151.3% | COM | 19243B102 |